Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001019056-17-000491
Filing Date
2017-05-23
Accepted
2017-05-23 17:25:38
Documents
1
Group Members
KNIGHT THERAPEUTICS (BARBADOS) INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A synergy_13da3.htm SC 13D/A 56129
  Complete submission text file 0001019056-17-000491.txt   57875
Mailing Address 865 SPRING STREET WESTBROOK ME 04092
Business Address 865 SPRING STREET WESTBROOK ME 04092 615-939-9004
Synergy CHC Corp. (Subject) CIK: 0001562733 (see all company filings)

EIN.: 990379440 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88542 | Film No.: 17864759
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address CHANCERY HOUSE HIGH STREET BRIDGETOWN C8 BB11128
Business Address CHANCERY HOUSE HIGH STREET BRIDGETOWN C8 BB11128 246-431-0070
Knight Therapeutics (Barbados) Inc. (Filed by) CIK: 0001632373 (see all company filings)

EIN.: 000000000 | State of Incorp.: C8 | Fiscal Year End: 1214
Type: SC 13D/A